These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2481368)

  • 21. Role of interferon in the resistance of C3H/HeJ mice to infection with herpes simplex virus.
    Chmielarczyk W; Domke I; Kirchner H
    Antiviral Res; 1985 Feb; 5(1):55-9. PubMed ID: 2580483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous herpes simplex virus-infected cells are lysed by human natural killer cells.
    Yasukawa M; Zarling JM
    J Immunol; 1983 Oct; 131(4):2011-6. PubMed ID: 6311903
    [No Abstract]   [Full Text] [Related]  

  • 23. The host response to herpes simplex virus infection.
    Pollara G; Katz DR; Chain BM
    Curr Opin Infect Dis; 2004 Jun; 17(3):199-203. PubMed ID: 15166821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral response to herpes simplex virus type 1 in latent and active infection.
    Santiago J; Gomez B
    J Infect Dis; 1988 Apr; 157(4):817-9. PubMed ID: 2831287
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells.
    López-Guerrero JA; Alarcón B; Fresno M
    J Gen Virol; 1988 Nov; 69 ( Pt 11)():2859-68. PubMed ID: 2846762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes simplex virus immunology: problems, progress, and promises.
    Kohl S
    J Infect Dis; 1985 Sep; 152(3):435-40. PubMed ID: 2993439
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells.
    Russell AS; Kaiser JT
    J Allergy Clin Immunol; 1976 Nov; 58(5):539-45. PubMed ID: 185242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
    Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
    Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specific protective immune mechanism in herpes simplex virus infection].
    Otani T; Mori R
    Uirusu; 1986 Dec; 36(2):221-32. PubMed ID: 3031876
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Langerhans cells and viral immunity.
    Cunningham AL; Carbone F; Geijtenbeek TB
    Eur J Immunol; 2008 Sep; 38(9):2377-85. PubMed ID: 18792031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 33. Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.
    Ennis FA
    J Infect Dis; 1973 Jun; 127(6):632-8. PubMed ID: 4350518
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of the in vitro-reactivation of latent herpes simplex virus infection in spinal ganglia: comparison of various immune factors. Brief report.
    von Rheinbaben F; Schneweis KE
    Arch Virol; 1986; 87(3-4):315-9. PubMed ID: 2418807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of recovery from systemic herpes simplex virus infection II. Effectiveness of antibody reconstitution of nude and neonatally thymectomized mice.
    Worthington M; Conliffe MA; Baron S
    Proc Soc Exp Biol Med; 1980 Dec; 165(3):462-8. PubMed ID: 6162165
    [No Abstract]   [Full Text] [Related]  

  • 36. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin Langerhans cells play an essential role in the defense against HSV-1 infection.
    Sprecher E; Becker Y
    Arch Virol; 1986; 91(3-4):341-9. PubMed ID: 3022684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Specific and unspecific immune stimulation in recurrent herpes simplex].
    Raab W
    Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NK cells and interferon as mediators of biological response modifier-mediated protection against MCMV and HSV-2 infection in normal and immunocompromised mice.
    Kunder SC; Morahan PS
    Ann N Y Acad Sci; 1993 Jun; 685():618-9. PubMed ID: 7689813
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental infection of inbred mice with herpes simplex virus. V. Investigations with a virus strain non-lethal after peripheral infection.
    Kümel G; Kirchner H; Zawatzky R; Engler H; Schröder CH; Kaerner HC
    J Gen Virol; 1982 Dec; 63(2):315-23. PubMed ID: 6185625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.